Action AstraZeneca (PK) - AZNCF

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

150,46

Prix Achat

149,05

Prix Vente

159,51

Volume échangé

1 846

0,00 Fourchette du Jour 0,00

120,6375 Plage de 52 semaines 175,00

Cap du marché

233,3B

Clôture Veille

150,46

Ouverture

Dernière Transaction

149.4799

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

2 961

Actions en circulation

1 550 581 134

Rendement du Dividende

2.28%

Ratio Cours sur Bénéfices

26,43

Bénéfice par action (BPA)

4,54

Chiffre d'affairess

54,07B

Bénéfice net

7,04B

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.astrazeneca.com

Siège social

Cambridge, Gbr

Fondé

AstraZeneca Plc (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker AZNCF. Le dernier cours de clôture d'AstraZeneca (PK) était de US$150,46. Au cours de la dernière année, les actions de AstraZeneca (PK) ont été négociées dans une fourchette de prix de US$ 120,6375 à US$ 175,00.

AstraZeneca (PK) compte actuellement 1 550 581 134 actions en circulation. La capitalisation boursière d'AstraZeneca (PK) est de US$233,30 milliard. AstraZeneca (PK) a un ratio cours/bénéfice (ratio PE) de 26.43.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	6.46	4.48611111111	144	155.65	142.4	2369	147.64774795	CS
4	10.28	7.33342844914	140.18	155.65	134.55	1922	145.1825371	CS
12	14.58	10.7300559317	135.88	155.65	125	2961	136.11811653	CS
26	-23.165	-13.3419726422	173.625	175	120.6375	2504	140.37365562	CS
52	23.5339	18.5414189832	126.9261	175	120.6375	2619	144.92435925	CS
156	28.54	23.4087926509	121.92	175	104.5	2860	135.47377099	CS
260	63.72	73.460917685	86.74	175	75.15	5337	115.46181847	CS

AZNCF - Frequently Asked Questions (FAQ)

What is the current AstraZeneca (PK) share price?

The current share price of AstraZeneca (PK) is US$ 150,46

How many AstraZeneca (PK) shares are in issue?

AstraZeneca (PK) has 1 550 581 134 shares in issue

What is the market cap of AstraZeneca (PK)?

The market capitalisation of AstraZeneca (PK) is USD 233,3B

What is the 1 year trading range for AstraZeneca (PK) share price?

AstraZeneca (PK) has traded in the range of US$ 120,6375 to US$ 175,00 during the past year

What is the PE ratio of AstraZeneca (PK)?

The price to earnings ratio of AstraZeneca (PK) is 26,43

What is the cash to sales ratio of AstraZeneca (PK)?

The cash to sales ratio of AstraZeneca (PK) is 3,44

What is the reporting currency for AstraZeneca (PK)?

AstraZeneca (PK) reports financial results in USD

What is the latest annual turnover for AstraZeneca (PK)?

The latest annual turnover of AstraZeneca (PK) is USD 54,07B

What is the latest annual profit for AstraZeneca (PK)?

The latest annual profit of AstraZeneca (PK) is USD 7,04B

What is the registered address of AstraZeneca (PK)?

The registered address for AstraZeneca (PK) is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA

What is the AstraZeneca (PK) website address?

The website address for AstraZeneca (PK) is www.astrazeneca.com

Which industry sector does AstraZeneca (PK) operate in?

AstraZeneca (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,02 (1 999 900,00%)	278
NLVVFNew Leaf Ventures (CE)	US$ 0,0089 (889 900,00%)	6,92k
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0,008 (799 900,00%)	101
ETBIEastgate Biotech Corporation (CE)	US$ 0,0045 (449 900,00%)	2k
VWESQVintage Wine Estates Inc (CE)	US$ 0,002 (199 900,00%)	3,44k
NEXINexImmune Inc (CE)	US$ 0,0001 (-99,90%)	13,59k
JERTQJER Investors Trust Inc New (CE)	US$ 0,000001 (-99,67%)	10k
AGILQAgileThought Inc (CE)	US$ 0,0001 (-99,10%)	4,7k
GAYGFMontauk Metals Inc (PK)	US$ 0,0012 (-99,08%)	6,25k
IONMAssure Holdings Corporation (CE)	US$ 0,000001 (-99,00%)	112
HMBLHUMBL Inc (PK)	US$ 0,0005 (25,00%)	279,83M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0026 (-3,70%)	123,47M
SPQSSportsQuest Inc (PK)	US$ 0,0001 (-50,00%)	114,57M
BOMObowmo Inc (PK)	US$ 0,0001 (0,00%)	102,85M
VTXBVortex Brands Company (PK)	US$ 0,0001 (0,00%)	101,18M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

AstraZeneca Plc (PK) (AZNCF) Cours

AstraZeneca Plc (PK) (AZNCF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de AstraZeneca Plc (PK)

AZNCF Dernières nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form F-6 - Registration of American Depository Receipt shares, not immediately effective

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

AZNCF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités